Information Collection Request

Evaluation of Medication- Assisted Treatment (MAT) for Opioid Use Disorders Study

ICR 201711-0920-009 · OMB 0920-1218 · Historical Active

Forms and Documents
DocumentTypeStatusAvailability
Client questionnaire - 24 month follow-up Form New Repair queued
Client questionnaire - 12 month follow-up Form New Available
Client Questionnaire - baseline Form New Available
Client Check-in Questionnaire Form New Repair queued
Client Screener Form New Repair queued
Attachment 10 IRB Documents 17ACE_MAT.PDF Supplementary Document Uploaded 2018-02-12 Repair queued
Att. 14_CoC for MAT Study.pdf Supplementary Document Uploaded 2018-02-12 Available
Att 6a. SSN collection.pdf Supplementary Document Uploaded 2018-02-12 Available
SSA_MAT_Clean_2.08.18.docx Supporting Statement A Uploaded 2018-02-12 Available
Signed CoC for study titled MAT Study.pdf Supplementary Document Uploaded 2017-11-08 Available
SSB_MAT_Clean_2.08.18.docx Supporting Statement B Uploaded 2018-02-12 Available
Attachment 13 Staff (Provider) Focus Group Consent 17ACE_MAT.docx Supplementary Document Uploaded 2017-11-08 Available
Attachment 12 Client Informed Consent_17ACE_MAT.docx Supplementary Document Uploaded 2017-11-08 Repair queued
Attachment 11 Client Supporting Documents 17ACE_MAT.docx Supplementary Document Uploaded 2017-11-08 Available
Attachment 10 IRB Documents 17ACE_MAT.pdf Supplementary Document Uploaded 2017-11-08 Available
Attachment 9 Privacy Impact Assessment 17ACE_MAT.pdf Supplementary Document Uploaded 2017-11-08 Available
Attachment 2 60 Day FRN 17ACE_MAT.pdf Supplementary Document Uploaded 2017-11-08 Available
Attachment 1 Authorizing Legislation.docx Supplementary Document Uploaded 2017-11-08 Available
IC Document Collections
IC IDCollectionTypeStatusForm
228981 Treatment Facility Staff Focus Groups Other-Focus group guide New
228980 Client Focus Groups Other-Focus group guide New
228979 Client questionnaire - 24 month follow-up Form New
228978 Client questionnaire - 12 month follow-up Form New
228977 Client Questionnaire - baseline Form New
228976 Client Check-in Questionnaire Form New
228975 Client Screener Form New
ICR Details
0920-1218 201711-0920-009
Historical Active
HHS/CDC 0920-17ACE
Evaluation of Medication- Assisted Treatment (MAT) for Opioid Use Disorders Study
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 02/12/2018
Retrieve Notice of Action (NOA) 12/07/2017
Approved consistent with the understanding that CDC will continue to coordinate opioid research efforts and outcomes with partners both within HHS and external (SAMHSA, NIH/NIDA, FDA)
  Inventory as of this Action Requested Previously Approved
02/28/2021 36 Months From Approved
6,871 0 0
3,093 0 0
0 0 0

Conduct an epidemiologic study to assess the real-world client outcomes of three types of Medication Assisted Treatment (MAT) and counseling without medication for individuals with Opioid Use Disorder (OUD). This study will also examine the contextual, provider, and individual factors that influence treatment implementation and client outcomes.

US Code: 42 USC 241 Name of Law: PHSA
  
None

Not associated with rulemaking

  82 FR 27832 06/19/2017
82 FR 57757 12/07/2017
Yes

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 6,871 0 0 6,871 0 0
Annual Time Burden (Hours) 3,093 0 0 3,093 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new ICR.

$1,940,535
Yes Part B of Supporting Statement
    Yes
    Yes
No
No
No
Uncollected
Shari Steinberg 404 639-4942 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
12/07/2017